Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martina L Porter

Showing results (31-40 of 63) with videos related to

Pageof 7
Sort By:
American Journal of Clinical Dermatology|July 26, 2024
Hidradenitis Suppurativa: New Targets and Emerging TreatmentsJulia L Gao, Tracey S Otto, Martina L Porter, et al.
Immunotherapy|October 16, 2023
Secukinumab in the treatment of hidradenitis suppurativaCorey L Snyder, Ruby S Gibson, Martina L Porter, et al.
International Journal of Women'S Dermatology|December 26, 2022
Travel burden on patients at a subspecialty hidradenitis suppurativa clinic: a single-center retrospective studyDiana S Kim, Nicole Giannotti, Prerna Salian, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|September 2, 2022
An Open-Label, Prospective, Pilot Study of Hypertonic Saline for Hidradenitis SuppurativaMartina L Porter, Prerna Salian, Monica Rosales Santillan, et al.
Journal of the American Academy of Dermatology|November 17, 2025
Efficacy and safety of ruxolitinib cream in patients with mild to moderate hidradenitis suppurativa: Results from a randomized, double-blind, vehicle-controlled phase 2 studyMartina L Porter, M Celeste Ferreira-Cornwell, Mingyue Wang, et al.
International Journal of Women'S Dermatology|January 19, 2024
Evaluating minority representation across health care settings in hidradenitis suppurativa and psoriasisCharlotte Greif, Ruby S Gibson, Alexa B Kimball, et al.
Expert Opinion on Pharmacotherapy|April 26, 2022
Advances in biologic and small molecule therapies for hidradenitis suppurativaStella X Chen, Charlotte Greif, Ruby S Gibson, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 11, 2025
Cumulative life course impairment: Evidence for hidradenitis suppurativaManeli Doroudian Tehrani, Ruby S Gibson, Corey L Snyder, et al.
JAMA Dermatology|May 8, 2024
Hematologic Abnormalities in Patients With Hidradenitis Suppurativa Receiving AdalimumabSimon J Gunter, Zachary E Holcomb, Barbara D Lam, et al.
International Journal of Women'S Dermatology|June 10, 2024
Data wobbles in hidradenitis suppurativa clinical trials and potential contributing factors: a retrospective reviewCorey L Snyder, Ruby S Gibson, Stella X Chen, et al.
Pageof 7

Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
American Journal of Clinical Dermatology|July 26, 2024
Hidradenitis Suppurativa: New Targets and Emerging TreatmentsJulia L Gao, Tracey S Otto, Martina L Porter, et al.
Immunotherapy|October 16, 2023
Secukinumab in the treatment of hidradenitis suppurativaCorey L Snyder, Ruby S Gibson, Martina L Porter, et al.
International Journal of Women'S Dermatology|December 26, 2022
Travel burden on patients at a subspecialty hidradenitis suppurativa clinic: a single-center retrospective studyDiana S Kim, Nicole Giannotti, Prerna Salian, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|September 2, 2022
An Open-Label, Prospective, Pilot Study of Hypertonic Saline for Hidradenitis SuppurativaMartina L Porter, Prerna Salian, Monica Rosales Santillan, et al.
Journal of the American Academy of Dermatology|November 17, 2025
Efficacy and safety of ruxolitinib cream in patients with mild to moderate hidradenitis suppurativa: Results from a randomized, double-blind, vehicle-controlled phase 2 studyMartina L Porter, M Celeste Ferreira-Cornwell, Mingyue Wang, et al.
International Journal of Women'S Dermatology|January 19, 2024
Evaluating minority representation across health care settings in hidradenitis suppurativa and psoriasisCharlotte Greif, Ruby S Gibson, Alexa B Kimball, et al.
Expert Opinion on Pharmacotherapy|April 26, 2022
Advances in biologic and small molecule therapies for hidradenitis suppurativaStella X Chen, Charlotte Greif, Ruby S Gibson, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 11, 2025
Cumulative life course impairment: Evidence for hidradenitis suppurativaManeli Doroudian Tehrani, Ruby S Gibson, Corey L Snyder, et al.
JAMA Dermatology|May 8, 2024
Hematologic Abnormalities in Patients With Hidradenitis Suppurativa Receiving AdalimumabSimon J Gunter, Zachary E Holcomb, Barbara D Lam, et al.
International Journal of Women'S Dermatology|June 10, 2024
Data wobbles in hidradenitis suppurativa clinical trials and potential contributing factors: a retrospective reviewCorey L Snyder, Ruby S Gibson, Stella X Chen, et al.
Pageof 7